Primaquine analogues that are potent anti-Trypanosoma cruzi agents in a mouse model

Ann Trop Med Parasitol. 1996 Oct;90(5):467-74. doi: 10.1080/00034983.1996.11813071.

Abstract

Seventy-seven primaquine analogues were evaluated for their effectiveness in reducing the parasitaemias in female albino mice (aged 4-6 weeks) which had been infected with a Brazilian strain of Trypanosoma cruzi 15 days earlier. Of the analogues tested, 23 were more effective than the reference drug, nifurtimox, and one was > 14-fold as effective as the standard and almost four times as active as primaquine itself. Certain members of the series tested warrant further evaluation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chagas Disease / drug therapy*
  • Chemistry, Pharmaceutical
  • Female
  • Mice
  • Primaquine / analogs & derivatives*
  • Primaquine / therapeutic use*
  • Trypanocidal Agents / therapeutic use*
  • Trypanosoma cruzi*

Substances

  • Trypanocidal Agents
  • Primaquine